The Collapse of 23andMe (Genetic Testing, Explained)

Genetic testing company, 23andMe, and it's founder Anne Wojiciki are on a mission to "revolutionise healthcare" - genotyping the world from just a single test tube of saliva... With backing from Google and GSK, how did the once valued $6 Billion dollar biotech startup collapse to a penny stock that now risks being delisted from the NASDAQ? Let's explore The Collapse of 23andMe.... Timestamps: 00:00 Prologue: The Collapse of 23andMe 01:23 NASDAQ Delisting 01:44 Genetic Testing, Explained 04:38 What Went Wrong? 06:09 Flawed Business Model 07:48 The Next Steps for 23andMe 09:31 Conclusion: The Beauty of DNA #BEYOND #DNA #23andMe #genetictesting "BEYOND, infinity" is a show that explores the future of science, health and tech. Subscribe for more vids like these :) -------------------------------- WHO AM I? Hey, I'm Esh - a medical student, podcaster and video journalist exploring the future of science, health and tech. I'm on a mission to tell stories that demonstrate why tech is so important for both our health and future.